Trial NCT02501473

View at ClinicalTrials.gov 
Org. Study IDs: 3475-174
Secondary IDs: 2015-005382-23 IMDZ-G142 MK-3475-174

Last trial update was posted on 2020-09-09

MeSH Interventions

Pembrolizumab Rituximab

MeSH Conditions

Lymphoma Lymphoma, Follicular Lymphoma, Non-Hodgkin

Other Conditions

Follicular Low Grade Non-Hodgkin's Lymphoma

Stopping Reasons

Business reasons

Limitations And Caveats

The study was terminated (halted prematurely) for business reasons.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID